ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GSK Gsk Plc

1,708.60
3.40 (0.20%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.40 0.20% 1,708.60 1,708.60 1,708.80 1,713.00 1,699.40 1,701.60 11,522,668 16:29:59
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.27 70.34B

GlaxoSmithKline's Trial Proves Efficacy of HIV's Prevention Cabotegravir

18/05/2020 7:59am

Dow Jones News


Gsk (LSE:GSK)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Gsk Charts.

By Sabela Ojea

 

GlaxoSmithKline PLC said Monday that interim analysis of the HIV Prevention Trials Network 083 study has proved the efficacy and safety of investigational, long-acting, injectable cabotegravir inhibitor for HIV prevention.

The British pharmaceutical giant said that the study of cabotegravir was 69% more effective in preventing HIV acquisition when administered every two months in men who have sex with men and transgender women who have sex with men "when compared to the current standard of care, daily oral emtricitabine/tenofovir" drugs.

The London-listed company added that the study had around 4,600 participants across America, Asia and Africa.

 

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

 

(END) Dow Jones Newswires

May 18, 2020 02:44 ET (06:44 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart

Your Recent History

Delayed Upgrade Clock